Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma

Authors
Bruno CostaJessica FlynnSham Mailankody
Journal
Blood Cancer Journal
Published
May 27, 2024
Loading PDF viewer…

Supporters

Support the authors with ResearchCoin

Topics

DOI

10.1038/s41408-024-01048-0

License

cc-by

Other Formats

Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma